Javascript must be enabled to continue!
Percutaneous Mitral Balloon Valvuloplasty: Technique and Results
View through CrossRef
Background: Percutaneous balloon mitral valvuloplasty is a procedure used to dilate the mitral valve in cases of rheumatic mitral stenosis. The catheter is inserted into the female vein to the right atrium and atrial septum. The mitral valve is then passed through the inflated balloon to facilitate effective integration of mitral adhesions, which increases the area of the mitral valve and decreases the rate of mitral stenosis. Mitral regurgitation is a potential problem, and thus balloon percutaneous mitral valvuloplasty (PBMV) is prevented in moderate to severe relapse. The Wilkins score studies mitral valve morphology and evaluation by echocardiography to assess the viability of PBMVs based on specific echocardiographic conditions.
Conclusion: There are many factors in the immediate and long-term outcomes of patients undergoing PMV. Echo-Sc can be used in combination with other clinical and morphological predictions of PMV effects to identify patients who experience the best effects on PMV.
Sciencedomain International
Title: Percutaneous Mitral Balloon Valvuloplasty: Technique and Results
Description:
Background: Percutaneous balloon mitral valvuloplasty is a procedure used to dilate the mitral valve in cases of rheumatic mitral stenosis.
The catheter is inserted into the female vein to the right atrium and atrial septum.
The mitral valve is then passed through the inflated balloon to facilitate effective integration of mitral adhesions, which increases the area of the mitral valve and decreases the rate of mitral stenosis.
Mitral regurgitation is a potential problem, and thus balloon percutaneous mitral valvuloplasty (PBMV) is prevented in moderate to severe relapse.
The Wilkins score studies mitral valve morphology and evaluation by echocardiography to assess the viability of PBMVs based on specific echocardiographic conditions.
Conclusion: There are many factors in the immediate and long-term outcomes of patients undergoing PMV.
Echo-Sc can be used in combination with other clinical and morphological predictions of PMV effects to identify patients who experience the best effects on PMV.
Related Results
Immediate maternal and fetal outcome following percutaneous mitral valve balloon commissurotomy: a 6-year single-center experience from sub-Saharan Africa
Immediate maternal and fetal outcome following percutaneous mitral valve balloon commissurotomy: a 6-year single-center experience from sub-Saharan Africa
AbstractBackground:Mitral stenosis is the most common valvular heart disease during pregnancy. When severe, it leads to significant maternal and fetal morbidity and mortality. Perc...
Prior surgical mitral commissurotomy and echocardiographic score influence in mitral balloon valvuloplasty. Immediate post procedure results
Prior surgical mitral commissurotomy and echocardiographic score influence in mitral balloon valvuloplasty. Immediate post procedure results
Abstract
Introduction
Percutaneous mitral balloon valvuloplasty is effective in mitral stenosis. Objectives: to evaluate prior m...
Mitral leaflet separation index correlation with mitral stenosis severity, a reliable easy 2-d echocardiography technique
Mitral leaflet separation index correlation with mitral stenosis severity, a reliable easy 2-d echocardiography technique
Objective: To evaluate accuracy of mitral leaflet separation index for the determination of mitral stenosis severity in patients with rheumatic mitral stenosis.
Method: The prospec...
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Percutaneous mitral balloon valvuloplasty
Percutaneous mitral balloon valvuloplasty
AbstractAlmost all mitral stenosis (MS) is rheumatic in etiology. The patient with MS who is symptomatic despite medical therapy should undergo percutaneous mitral balloon valvulop...
Restenosis after Percutaneous Balloon Mitral Valvuloplasty in Patients with Previous Surgery
Restenosis after Percutaneous Balloon Mitral Valvuloplasty in Patients with Previous Surgery
To identify the risk factors of restenosis after balloon mitral valvuloplasty in patients with mitral restenosis after surgical valvotomy, we obtained 30.4 ± 13.0 months (range 6 t...
ANALYSIS OF 293 CASES AFTER PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY
ANALYSIS OF 293 CASES AFTER PERCUTANEOUS BALLOON MITRAL VALVULOPLASTY
Objectives
To observe the short-term results and appropriateness of the use of percutaneous balloon mitral valvuloplasty (PBMV) on the patients with rheumatic mit...
GW24-e0772 Clinical efficacy of Wilkins integral in patients with percutaneous balloon mitral valvuloplasty
GW24-e0772 Clinical efficacy of Wilkins integral in patients with percutaneous balloon mitral valvuloplasty
Objectives
To investigate patients with mitral stenosis of the valve morphology passing through the short-term effect of balloon mitral valvuloplasty.
...

